Health Care & Life Sciences » Pharmaceuticals | Ono Pharmaceutical Co. Ltd.

Ono Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
127,993
127,788
132,868
164,683
85,743
71,468
Total Accounts Receivable
42,240
41,960
62,043
73,255
81,196
76,285
Inventories
24,261
25,805
23,232
26,881
33,138
32,821
Other Current Assets
1,063
2,312
5,430
6,214
9,387
14,042
Total Current Assets
195,557
197,865
223,573
271,033
209,464
194,617
Net Property, Plant & Equipment
59,147
70,754
80,094
83,659
94,321
108,870
Total Investments and Advances
196,059
220,295
190,889
204,319
236,462
263,261
Intangible Assets
22,690
33,913
38,324
45,237
55,715
63,059
Other Assets
2,685
1,716
2,391
2,475
3,072
4,171
Total Assets
486,141
524,588
540,450
617,461
609,226
655,056
ST Debt & Current Portion LT Debt
508
287
328
423
392
Accounts Payable
4,084
3,779
9,793
7,128
5,622
Income Tax Payable
4,303
6,587
6,585
24,777
8,742
Other Current Liabilities
19,377
24,344
35,488
50,605
53,713
Total Current Liabilities
28,272
34,997
52,194
82,933
68,469
Long-Term Debt
468
317
515
542
320
Provision for Risks & Charges
4,032
5,515
4,123
2,269
3,887
Deferred Taxes
9,001
1,111
4,294
9,858
9,176
Other Liabilities
643
7,390
6,478
5,493
5,321
Total Liabilities
34,417
49,375
64,195
92,118
79,013
Common Equity (Total)
447,327
470,575
471,393
519,110
524,390
Total Shareholders' Equity
447,327
470,575
471,393
519,110
524,390
Total Equity
451,724
475,213
476,255
524,211
529,618
Liabilities & Shareholders' Equity
486,141
524,588
540,450
616,329
608,631
Accumulated Minority Interest
4,397
4,638
4,862
5,101
5,228

About Ono Pharmaceutical Co.

View Profile
Address
1-8-2 Kyutaromachi
Osaka Osaka 541
Japan
Employees -
Website http://www.ono.co.jp
Updated 07/08/2019
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan. .